Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Compai Pharma is a Singapore-based private healthcare commercialization and distribution company focused on bringing pharmaceutical products, diagnostics, and medical devices to Southeast Asia, particularly Singapore and Malaysia. Rather than operating as a drug-discovery biotech, the company works through in-licensing, market access, medical affairs, sales and marketing, distribution, and strategic partnerships with international healthcare companies. Its commercial portfolio spans women’s health, oncology, gastroenterology, infectious disease diagnostics, and blood management, including products such as Monofer, Guardant360, Guardant Reveal, Actim rapid tests, and Cumlaude Lab women’s health products. The company has also partnered with EVERSANA to expand commercialization services across APAC and appears to operate under the umbrella of Tiash Group/NAVA-linked healthcare activities. Overall, Compai Pharma is best understood as a regional specialty pharma and medtech commercial partner rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Compai Pharma.